Recent Blog Posts
-
Cable Companies Assail Rural Phone Subsidies
Nov 06 20092:16 pm EDT -
Windows 7 Sales Are Strong
Nov 06 20097:46 am EDT -
Biotech Firm Light Sciences Raises $35 Million
Nov 05 20095:57 pm EDT -
Tough VC Market Claims Frazier Technology
Nov 05 20098:02 am EDT -
Digby Buys Mobile Commerce Site Movaya
Nov 04 20091:08 pm EDT
Links
- Engadget
- Pandora
- GigaOM
- USA TODAY Tech
- Todd Bishop's Microsoft Blog
- Somewhat Frank's tech conference list
- BuzzTracker Tech
- The Long Tail
- Tom Foremski
- Roger McGuinn's Folk Den
- John Battelle's SearchBlog
- Mark Cuban's blog
- SciTech Daily
- Romenesko
- Kevin Maney's site
- Steven Johnson
- Marc Andreessen
- TechCrunch
- Fred Wilson
- paidContent
- Spiedies, mmmm
Jul 23 2008 12:00am EDT
Questcor: From Orphan Drug To Orphan Stock?
Blaise Zerega can't fathom an 1,800% price hike. Russ Mitchell's examination yesterday of why Questcor Pharmaceuticals raised the price of a drug used to treat infantile epilepsy from $1,600 per vial to $23,000 per vial helps set the stage for Congressional hearings tomorrow. But in the meanwhile, the company's share price is already taking a hit, down 9% to $4.57 as of this posting. What if it QCOR shares eventually fell 1,800%? Instant karma, anyone?
. □
